Here are Jefferies’ top stock picks for the summer

Jefferies analysts have released their top stock picks for the summer, highlighting 28 buy-rated, high-conviction ideas poised to perform well regardless of market conditions. Key picks include Nvidia, with a price target of $185 driven by its dominance in AI accelerators and the ramp-up of its Blackwell GPU platform; Dexcom, with a $110 target based on expansion into the Type 2 non-insulin market and FDA approval of its 15-day glucose monitoring sensor; and Capital One, with a $230 target citing the completed merger with Discover Financial Services and improving credit trends.

Analysis

Market sentiment reflects a recent rebound, with the S&P 500 gaining 6.2% in May, its strongest monthly performance since November 2023, yet investor outlook remains divided with Fundstrat's Tom Lee heralding a 'rebirthed bull market' while Evercore's Julian Emanuel cautions of potential 'rocky times ahead,' particularly amidst ongoing trade policy uncertainties. In this environment, Jefferies has presented 28 high-conviction, buy-rated stock picks designed to perform across varying market conditions. Key selections include Nvidia (NVDA), targeted at $185 (31% upside from Tuesday's settlement), based on its leadership in AI accelerators and the imminent margin-enhancing ramp of its Blackwell GPU platform, expected to lift gross margins from the low-70% to mid-70% range; NVDA shares are up 5% this year. Dexcom (DXCM) is also highlighted with a $110 price target (nearly 27% upside), driven by its strategic expansion into the Type 2 non-insulin patient market and the recent FDA approval of its 15-day glucose sensor, a potential margin driver; DXCM shares have risen 11% in 2025, according to the article. Capital One (COF), which has rallied over 9% this year, is favored with a $230 price target (almost 18% upside), due to the completed Discover Financial Services merger, which Jefferies anticipates will yield significant network and operating expense synergies, complemented by improving credit trends and potential for higher net interest margins and reserve releases. Jefferies notes these picks are supported by differentiated analysis, identifiable catalysts, and attractive valuation levels.

Key Decisions for Investors

• Investors should evaluate potential exposure to Jefferies' high-conviction buy-rated stocks, particularly Nvidia, Dexcom, and Capital One, given the firm's detailed catalysts and projected upside percentages.
• Closely monitor the execution of company-specific drivers for these highlighted names: Nvidia's Blackwell platform adoption and its impact on gross margins, Dexcom's market penetration in the Type 2 non-insulin segment and margin benefits from its new 15-day sensor, and Capital One's successful integration of Discover Financial Services for synergy realization alongside evolving credit trends and net interest margin performance.
• While these specific opportunities are presented with a positive outlook, investors should remain cognizant of the broader market's mixed signals and persistent uncertainties, such as trade policy, necessitating a balanced approach to risk management despite the recent market rally.